Akouos, Inc.
(NASDAQ GS: AKUS)
Rigrodsky Law, P.A. is investigating Akouos, Inc. (“Akouos”) regarding possible breaches of fiduciary duties and other violations of law related to Akouos’ agreement to be acquired by Eli Lilly and Company. Under the terms of the agreement, Akouos’ shareholders will receive $12.50 per share plus one contingent value right (“CVR”), which represents the contractual right to receive contingent payments up to $3.00 per CVR.